Zongjuan Li
- Cancer Research top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 5
- Cancer-related Molecular Pathways 4
-
- interferon and immune responses 4
- Immune cells in cancer 4
-
- Lung Cancer Treatments and Mutations 3
-
- RNA modifications and cancer 3
- Genomics, phytochemicals, and oxidative stress 2
-
- Thyroid Cancer Diagnosis and Treatment 3
- Co-authors
- Lijuan ZouKun ZouWuguo DengWei GuoZhao‐Chong ZengShisuo DuWendan YuYi‐Jun Hua
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (1 paper)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zongjuan Li
28 papers receiving 780 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 182
- Oncology 259
- Immunology 188
- Pulmonary and Respiratory Medicine 189
- Molecular Biology 384
Countries citing papers authored by Zongjuan Li
This map shows the geographic impact of Zongjuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongjuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongjuan Li more than expected).
Fields of papers citing papers by Zongjuan Li
This network shows the impact of papers produced by Zongjuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongjuan Li. The network helps show where Zongjuan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zongjuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 28 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 73 | |
| 10 | 2021 | 47 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 34 | |
| 14 | 2020 | 120 | |
| 15 | 2020 | 105 | |
| 16 | 2019 | 19 | |
| 17 | 2018 | 13 | |
| 18 | 2018 | 31 | |
| 19 | 2017 | 63 | |
| 20 | 2017 | 2 |
About Zongjuan Li
Zongjuan Li is a scholar working on Oncology, Immunology and Hepatology, having authored 29 papers that have together received 783 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), interferon and immune responses (4 papers), Cancer-related Molecular Pathways (4 papers), Immune cells in cancer (4 papers), Lung Cancer Treatments and Mutations (3 papers), RNA modifications and cancer (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). The work is most often cited by research in Cancer Research (182 citations), Oncology (259 citations) and Immunology (188 citations). Zongjuan Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lijuan Zou, Kun Zou, Wuguo Deng, Wei Guo, Zhao‐Chong Zeng, Shisuo Du, Wendan Yu, Yi‐Jun Hua, Silei Sui and Yuqing Xiong. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.